Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas

A pair of 35 kDa polypeptides (TAO1/TAO2) are expressed in more than 90% of all primary lung adenocarcinomas but not in other major malignancies. Mass spectrometry of tryptic peptides showed that TAO1/TAO2 is identical to napsin A, a recently described member of the aspartic proteinase family. The s...

Full description

Saved in:
Bibliographic Details
Published inFEBS letters Vol. 462; no. 1; pp. 129 - 134
Main Authors Chuman, Yoshiko, Bergman, Ann-Charlotte, Ueno, Takayuki, Saito, Shin’ichi, Sakaguchi, Kazuyasu, Alaiya, Ayodele A., Franzén, Bo, Bergman, Tomas, Arnott, David, Auer, Gert, Appella, Ettore, Jörnvall, Hans, Linder, Stig
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 26.11.1999
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A pair of 35 kDa polypeptides (TAO1/TAO2) are expressed in more than 90% of all primary lung adenocarcinomas but not in other major malignancies. Mass spectrometry of tryptic peptides showed that TAO1/TAO2 is identical to napsin A, a recently described member of the aspartic proteinase family. The site of processing of pronapsin A to the mature form was located. Napsin expression was detected in human lung adenocarcinoma tumors, compatible with the marker nature of TAO1/TAO2 in the diagnosis of primary lung adenocarcinoma. This is important since identification of markers which can distinguish primary lung adenocarcinomas from distant metastases is desirable. Northern blot analysis showed expression of napsin also in normal lung and kidney tissue, and in situ hybridization showed expression in type II alveolar cells of the lung. This protease is concluded to have a specific functional role in the normal alveolar epithelium and is a candidate protease for the proteolytic processing of surfactant precursors.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-5793
1873-3468
DOI:10.1016/S0014-5793(99)01493-3